Eric Smith

ORCID: 0000-0003-2369-8870
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research
  • Cytokine Signaling Pathways and Interactions
  • interferon and immune responses
  • Trauma and Emergency Care Studies
  • Genomics, phytochemicals, and oxidative stress
  • Cancer-related Molecular Pathways
  • Cardiac Arrest and Resuscitation
  • Glutathione Transferases and Polymorphisms
  • Medical Imaging and Analysis
  • Immune Response and Inflammation
  • Trauma, Hemostasis, Coagulopathy, Resuscitation
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Cell death mechanisms and regulation
  • Venous Thromboembolism Diagnosis and Management
  • Mitochondrial Function and Pathology
  • Multiple Myeloma Research and Treatments
  • Angiogenesis and VEGF in Cancer
  • MicroRNA in disease regulation
  • Genomics and Chromatin Dynamics
  • Salmonella and Campylobacter epidemiology
  • Viral-associated cancers and disorders
  • Glycosylation and Glycoproteins Research
  • Vitamin C and Antioxidants Research

Regeneron (United States)
2009-2023

Memorial Sloan Kettering Cancer Center
2020

Cornell University
2020

Case Western Reserve University
2019-2020

University Hospitals of Cleveland
2019-2020

University School
2019-2020

Stryker (United States)
2019

Cedars-Sinai Medical Center
2015-2018

California State University, San Marcos
2017

University of California, San Francisco
2015-2016

Interferons constitute the earliest immune response against viral infection. They elicit antiviral effects as well multiple biological responses involved in cell growth regulation and activation. Because interferon-induced cellular is primary defense mechanism infection, many viruses have evolved strategies to antagonize inhibitory of interferon. Here, we demonstrate a strategy that Kaposi's sarcoma-associated herpesvirus uses block virus-mediated induction type I We found immediate-early...

10.1073/pnas.082420599 article EN Proceedings of the National Academy of Sciences 2002-04-09

Induction of interferon-alpha (IFNalpha) gene expression in virus-infected cells requires phosphorylation-induced activation the transcription factors IRF3 and IRF7. However, kinase(s) that targets these proteins has not been identified. Using a combined pharmacological genetic approach, we found none kinases tested was responsible for IRF phosphorylation infected with Newcastle disease virus (NDV). Although broad-spectrum kinase inhibitor staurosporine potently blocked -7 phosphorylation,...

10.1074/jbc.m008717200 article EN cc-by Journal of Biological Chemistry 2001-03-01

Previous studies have demonstrated cell cycle-dependent specificities in the interactions of E2F proteins with Rb family members. We now show that formation an E2F-p130 complex is unique to cells a quiescent, G0 state. The does not reform when reenter proliferative state and cycle through G1. presence quiescent coincides E2F-mediated repression transcription E2F1 gene, we sites promoter are important as enter quiescence but play no apparent role cycling cells. In addition, decay requires...

10.1128/mcb.16.12.6965 article EN Molecular and Cellular Biology 1996-12-01

Bispecific antibodies, while showing great therapeutic potential, pose formidable challenges with respect to their assembly, stability, immunogenicity, and pharmacodynamics. Here we describe a novel class of bispecific antibodies native human immunoglobulin format. The design exploits differences in the affinities isotypes for Protein A, allowing efficient large-scale purification. Using this format, generated antibody, REGN1979, targeting B cell marker, CD20, CD3 component T receptor, which...

10.1038/srep17943 article EN cc-by Scientific Reports 2015-12-11

Background Current measurements of multiple myeloma disease burden are suboptimal. Daratumumab is a monoclonal antibody that targets CD38, an antigen expressed on nearly all cells. Purpose To demonstrate preclinical and first-in-human application composed the native daratumumab labeled with positron-emitting radionuclide zirconium 89 (89Zr) through chelator deferoxamine (DFO), or 89Zr-DFO-daratumumab, for immunologic PET imaging myeloma. Materials Methods 89Zr-DFO-daratumumab was synthesized...

10.1148/radiol.2020192621 article EN Radiology 2020-04-07

Abstract T-cell-redirecting bispecific antibodies have emerged as a new class of therapeutic agents designed to simultaneously bind T cells via CD3 and tumor tumor-cell-specific antigens (TSA), inducing T-cell-mediated killing cells. The promising preclinical clinical efficacy TSAxCD3 is often accompanied by toxicities such cytokine release syndrome due T-cell activation. How the toxicity profile depends on binding affinity remains unclear. Here, we evaluate that were engineered range...

10.1038/s41598-021-93842-0 article EN cc-by Scientific Reports 2021-07-13

Previous work has demonstrated the critical role for transcription repression in quiescent cells through action of E2F-Rb or E2F-p130 complexes. Recent studies have shown that at least one mechanism this involves recruitment histone deacetylase. Nevertheless, these also suggest other events likely contribute to E2F/Rb-mediated repression. Using a yeast two-hybrid screen identify proteins specifically interact with Rb-related p130 protein, we demonstrate p130, as well Rb, interacts protein...

10.1073/pnas.96.17.9574 article EN Proceedings of the National Academy of Sciences 1999-08-17

Abstract Lymphocytes derived from mice deficient in STAT1 showed reduced apoptosis and enhanced proliferation vitro. To understand the involvement of observed reduction apoptosis, we examined levels caspase bcl-2 family genes that are involved cell survival and/or apoptosis. The 1 11, two enzymes both cytokine protein processing induction were STAT1−/− cells compared with wild-type. However, comparable mice. also displayed an following TCR stimulation. This hyperproliferation could not be...

10.4049/jimmunol.164.3.1286 article EN The Journal of Immunology 2000-02-01

Interferon regulatory factor 7 (IRF7) is an interferon (IFN)-inducible transcription required for activation of a subset IFN-α genes that are expressed with delayed kinetics following viral infection. IRF7 synthesized as latent protein and posttranslationally modified by phosphorylation in infected cells. Phosphorylation carboxyl-terminal domain controlled the retention active exclusively nucleus, well its binding to specific DNA target sequences, multimerization, ability induce gene...

10.1128/mcb.20.23.8803-8814.2000 article EN cc-by Molecular and Cellular Biology 2000-12-01

Type I interferon (IFN) is synthesized by most nucleated cells following viral infection. Robust IFN production in cell culture requires positive feedback expression of inducible signaling components, such as the transcription factor IRF7. However, role and IRF7 vivo may be more complex. We found that produced locally respiratory tract influenza virus-infected mice displayed characteristics feedback, including Stat1-dependent induction gene expression. was similarly stimulus-dependent...

10.1074/jbc.m501289200 article EN cc-by Journal of Biological Chemistry 2005-03-15

CD3-engaging bispecific antibodies (bsAbs) and chimeric antigen receptor (CAR) T cells are potent therapeutic approaches for redirecting patient to recognize kill tumors. Here we describe a fully human bsAb (REGN5458) that binds B-cell maturation (BCMA) CD3, compare its antitumor activities vs those of anti-BCMA CAR identify differences in efficacy mechanism action. In vitro, BCMAxCD3 efficiently induced polyclonal T-cell killing primary plasma multiple myeloma (MM) cell lines expressing...

10.1182/bloodadvances.2020002736 article EN cc-by-nc-nd Blood Advances 2021-03-02

Abstract The Notch ligand delta-like 4 (Dll4) has been identified as a promising target in tumor angiogenesis preclinical studies, and Dll4 inhibitors have recently entered clinical trials for solid tumors, including ovarian cancers. In this study, we report the development of REGN421 (enoticumab), fully human IgG1 monoclonal antibody that binds with sub-nanomolar affinity inhibits signaling. Administering to immunodeficient mice engineered express inhibited growth several xenografts...

10.1158/0008-5472.can-14-3773 article EN Cancer Research 2015-09-17

Abstract Patients with hematologic cancers have improved outcomes after treatment bispecific antibodies that bind to CD3 on T cells and redirect toward cancer cells. However, clinical benefit against solid tumors remains be shown. We made a antibody targets both the common prostate tumor–specific antigen PSMA (PMSAxCD3) provide evidence for tumor inhibition in several preclinical models. Mice expressing human extracellular regions of were generated examine antitumor efficacy presence an...

10.1158/2326-6066.cir-19-0518 article EN Cancer Immunology Research 2020-03-17

Human illness due to Camplyobacter jejuni infection is closely associated with consumption of poultry products. We previously demonstrated a 50 % shift in allele frequency (phase variation) contingency gene Cj1139 (wlaN) during passage C. NCTC11168 populations through Ross 308 broiler chickens. hypothesized that phase variation genes chicken could promote subsequent colonization and disease humans. To test this hypothesis, we passaged strains NCTC11168, 33292, 81-176, KanR4 CamR2 chickens...

10.1099/mic.0.057158-0 article EN Microbiology 2012-02-17
Coming Soon ...